GoHealth, Inc. (NASDAQ:GOCO) Short Interest Down 27.4% in September

Key Points

• GoHealth, Inc. experienced a substantial decrease in short interest, falling by 27.4% in September, with a total of 120,500 shares short sold by mid-month.
• The company's stock has been downgraded by multiple analysts, with Weiss Ratings maintaining a "sell" rating and Royal Bank of Canada reducing its price target from $18.00 to $12.00.
• GoHealth reported a net loss of ($1.23) earnings per share for the last quarter, which was better than analyst expectations, though revenue fell short at $94.05 million compared to projected figures.

GoHealth, Inc. (NASDAQ:GOCO - Get Free Report) saw a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 120,500 shares, a decrease of 27.4% from the August 31st total of 165,900 shares. Based on an average daily trading volume, of 47,500 shares, the days-to-cover ratio is presently 2.5 days. Currently, 1.1% of the shares of the stock are short sold. Currently, 1.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 47,500 shares, the days-to-cover ratio is presently 2.5 days.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on GOCO. Weiss Ratings restated a "sell (e+)" rating on shares of GoHealth in a report on Saturday, September 27th. Wall Street Zen downgraded GoHealth from a "hold" rating to a "sell" rating in a research note on Friday, July 18th. Royal Bank Of Canada decreased their price objective on shares of GoHealth from $18.00 to $12.00 and set a "sector perform" rating on the stock in a research report on Thursday, August 28th. Finally, Noble Financial reissued an "outperform" rating on shares of GoHealth in a research note on Friday, August 8th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, GoHealth presently has a consensus rating of "Hold" and an average target price of $12.00.

GoHealth Stock Up 3.8%

GOCO opened at $4.90 on Tuesday. The firm has a market cap of $140.18 million, a P/E ratio of -1.36 and a beta of 1.62. The business's fifty day simple moving average is $5.19 and its 200 day simple moving average is $6.92. GoHealth has a 52 week low of $4.32 and a 52 week high of $21.00. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 2.64.

GoHealth (NASDAQ:GOCO - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($1.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.60) by $1.37. The company had revenue of $94.05 million for the quarter, compared to analysts' expectations of $119.76 million. GoHealth had a negative net margin of 3.21% and a negative return on equity of 8.74%. As a group, equities research analysts anticipate that GoHealth will post -5.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in GOCO. Bank of America Corp DE lifted its position in GoHealth by 22.8% during the fourth quarter. Bank of America Corp DE now owns 7,831 shares of the company's stock worth $105,000 after buying an additional 1,452 shares during the period. Millennium Management LLC purchased a new position in shares of GoHealth during the 4th quarter worth about $144,000. FNY Investment Advisers LLC acquired a new stake in shares of GoHealth in the first quarter worth approximately $31,000. N.E.W. Advisory Services LLC purchased a new stake in GoHealth in the first quarter valued at approximately $45,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in GoHealth in the first quarter valued at approximately $212,000. Hedge funds and other institutional investors own 24.21% of the company's stock.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.